BRIEF published on 06/29/2026 at 18:35, 1 month 10 days ago SEMCO Technologies launches share buyback program Share Buyback Euronext Growth Buyback Program General Assembly SEMCO Technologies
BRIEF published on 06/12/2026 at 17:50, 1 month 27 days ago Provision of documents for the SEMCO Technologies AGM Shareholder Vote General Assembly Preparatory Documents BALO SEMCO Technologies
BRIEF published on 05/21/2026 at 07:50, 2 months 20 days ago SEMCO Technologies Completes €50 Million Share Sale Private Placement Institutional Investors Share Sale Growth Trajectory SEMCO Technologies
PRESS RELEASE published on 05/21/2026 at 07:45, 2 months 20 days ago Inside Information / Operations of the issuer (acquisitions, sales...) SEMCO Technologies announces successful completion of a €50 million share sale by its main shareholder, expanding company's capital and increasing free float Share Sale SEMCO Technologies Capital Expansion Free Float Increase Main Shareholder
BRIEF published on 05/20/2026 at 17:50, 2 months 20 days ago SEMCO Technologies Expands Production Capacity in Montpellier Automation Production Expansion SEMCO Technologies Montpellier Site Semiconductor Components
PRESS RELEASE published on 05/20/2026 at 17:45, 2 months 20 days ago Inside Information / Other news releases SEMCO Technologies secures independent extension of production capacity in Montpellier to support future growth, enhancing flexibility and productivity Extension Growth Production Capacity Montpellier SEMCO Technologies
BRIEF published on 03/23/2026 at 07:35, 4 months 18 days ago SEMCO Technologies entrusts its liquidity contract to Portzamparc Liquidity Contract PORTZAMPARC Euronext Growth SEMCO Technologies SEMCO Shares
BRIEF published on 07/29/2025 at 08:35, 1 year ago SEMCO Technologies Concludes Successful IPO with €46.2 Million Raised Liquidity Contract Free Float IPO Success Over-allotment Option SEMCO Technologies
PRESS RELEASE published on 07/29/2025 at 08:30, 1 year ago Inside Information / Other news releases SEMCO confirms success of IPO with €1.2 million over-allotment option and total offering amount of €46.2 million. Liquidity contract with Gilbert Dupont established. Stabilisation period ends on 28 July 2025 Liquidity Contract IPO Stabilisation Period Over-allotment Option SEMCO
Published on 08/10/2026 at 15:30, 40 minutes ago Silver Spruce Resources, Inc. Announces New Chief Financial Officer
Published on 08/10/2026 at 15:25, 45 minutes ago Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland
Published on 08/10/2026 at 14:30, 1 hour 40 minutes ago NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
Published on 08/10/2026 at 13:30, 2 hours 40 minutes ago Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
Published on 08/10/2026 at 13:00, 3 hours 10 minutes ago Alaska Energy Metals Announces Drilling Program for the Mcbride Prospect, Angliers-Belleterre Project, Quebec, Canada
Published on 08/10/2026 at 15:56, 14 minutes ago Viromed Medical AG signs distribution partnerships for ViroCAP® in six additional markets
Published on 08/10/2026 at 15:46, 24 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 08/10/2026 at 15:44, 25 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 08/10/2026 at 11:53, 4 hours 16 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 4 hours 34 minutes ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 6 hours 48 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 07:00, 9 hours 10 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/07/2026 at 18:54, 2 days 21 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
